Yep great salesmen and marketers but the actual product appears sub standard and once deployed, customers appear to realise and are slow to pay for it. IMO going to zero. MC is heading toward cash backing. Market isn't pricing much value into the company beyond the bank balance. Next cash burning 4C due to drop in a few weeks.
- Forums
- ASX - By Stock
- Ann: Annual Report to shareholders
Yep great salesmen and marketers but the actual product appears...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DUB (ASX) to my watchlist
|
|||||
Last
4.4¢ |
Change
-0.001(2.22%) |
Mkt cap ! $40.43M |
Open | High | Low | Value | Volume |
4.6¢ | 4.6¢ | 4.4¢ | $83.57K | 1.845M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 11999 | 4.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.6¢ | 222222 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 11999 | 0.044 |
1 | 60000 | 0.043 |
1 | 60000 | 0.042 |
3 | 368316 | 0.041 |
5 | 328300 | 0.040 |
Price($) | Vol. | No. |
---|---|---|
0.046 | 222222 | 1 |
0.047 | 50023 | 1 |
0.048 | 60000 | 1 |
0.049 | 600000 | 2 |
0.050 | 341992 | 5 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
DUB (ASX) Chart |